iSCIB1+ DNA vaccine (Scancell)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameiSCIB1+ DNA vaccine (Scancell)

Drug Alias NameiSCIB1+

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineCell and gene therapy > Gene therapy > Plasmid

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSkin MelanomaMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesScancell Ltd

China Registration ClassN/A

Develop Information

Active CompaniesScancell Ltd

Inactive CompaniesN/A

Active IndicationsSkin MelanomaMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A